Michael J. Fox Foundation for Parkinson’s Research (MJFF)


Applicant will be asked to justify the therapeutic targets relevant for PD, provide details of the therapeutic strategy, and clearly identify any suboptimal properties of their therapeutic strategy. Considerations include:

The target and pathway proposed:
What is the relevance of the proposed target for PD?
What is the relationship of the proposed target within the pathway in which it is implicated to other potential targets?
Why is the proposed target the most relevant in that pathway – in comparison to other targets in the same pathway?

The therapeutic strategy:
Current drug development stage with clear justification
Provide research operation plan, including feasibility, timelines, and all assays to be performed
Provide a clear description (strengths and weaknesses) of the properties of the proposed therapeutic

Termini IISPV

Declaration of interest: IISPV’s deadline:  April 24, 2014 (europa@iispv.cat). Pre-proposal: IISPV’s deadline: May 21, 2014.

Termini Oficial

Pre-proposals Due: May 28, 2014 – 6pm US ET
Full Proposal Invitations: June 18, 2014
Full Proposals Due (by invite only): August 6, 2014 – 6pm US ET
Anticipated Award Announcement: October 2014
Anticipated Funding: November 2014

Estàs interessat?

Omple el següent formulari per rebre més informació: